Articles
Robust Signal Management to Achieve Patient Safety-Signal Case Study
Posted on October 3, 202310/3/23
Successful Implementation of End-To-End Pharmacovigilance Services For Drug-Device Combination Product Portfolio
Posted on October 3, 202310/3/23
FDA Inspection Win for Mid-Sized Pharma (50+ Products) with Extensive Generic Product Portfolio
Posted on October 3, 202310/3/23
FDA Inspection Win For a Mid-Sized Pharma Company with More Than 40+ Products in the USA and Outside the USA
Posted on October 3, 202310/3/23
Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)
- Journal/Conference:
- ASH 2020
- Author(s):
- Chen, C., Disher, T., Siddiqui, M., La Torre, I., Skikne, B., Suero, B., Cameron, H., Gavanji, R., Cameron, C.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Oncology
Reduced Hospital Costs for Ultrasound-guided Vacuum-assisted Excision Compared with Open Surgery in Patients with Benign Breast Masses and High-risk Lesions.
- Journal/Conference:
- Journal of Breast Imaging
- Author(s):
- Whitworth, P.: Hogan, A.: Ferko, N.: Son, D.: Wang, F.: Xiong, Y.: Suri, H.: Barclay, B.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Breast Cancer
Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis
- Journal/Conference:
- Current medical research and opinion
- Author(s):
- Chen, S.: Zhou, A.: Emmanuel, B.: Thomas, K.: Guiang, H.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Respiratory
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective
- Journal/Conference:
- Journal of Medical Economics
- Author(s):
- Kilcoyne, A.; Jordan, E.; Zhou, A.; Thomas, K.; Pepper, A.N.; Chappell, D; Amarapala, M.; Hughes, A.; Thompson, M.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- COVID-19, Respiratory
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
- Journal/Conference:
- Clinicoeconomic Outcomes Research0
- Author(s):
- Kilcoyne, A.; Jordan, E.; Thomas, K.; Pepper, A.N.; Zhou, A.; Chappell, D.; Amarapala, M.; Thériault, R.K.; Thompson, M. Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- COVID-19, Respiratory
Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease; A Meta-analysis and matching-adjusted indirect comparison
- Journal/Conference:
- JAMA Opthamology
- Author(s):
- Douglas, R.S.; Dailey, R.; Subramanian, P.S.; Barbesino, G.; Ugradar, S.; Batten, R.; Qadeer, R.A.; Cameron, C.
- Publication Date:
- 2022
- Topic/Therapeutic Area:
- Eye, Vision